Mouse models have shown that conditional deletion of the TGFβ receptor, ALK5, or the SMAD2 and SMAD3 transcription factors in the endometrial epithelium and stroma17 results in aggressive metastatic endometrial cancer and death18,19. The gene discussed is SMAD2; the disease is endometrial cancer.